| 2022 | Lee SH, Ha SY, Sym SJ. A urethral clear cell carcinoma case successfully treated with organ preservation surgery and adjuvant chemoradiation. Urol Case Rep. 2022 Jun 5;44:102124. doi: 10.1016/j.eucr.2022.102124. eCollection 2022 Sep. |
| 2022 | Osong B, Masciocchi C, Damiani A, Bermejo I, Meldolesi E, Chiloiro G, Berbee M, Lee SH, Dekker A, Valentini V, Gerard JP, Rödel C, Bujko K, van de Velde C, Folkesson J, Sainato A, Glynne-Jones R, Ngan S, Brændengen M, Sebag-Montefiore D, van Soest J. Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery. Phys Imaging Radiat Oncol. 2022 Mar 29;22:1-7. doi: 10.1016/j.phro.2022.03.002. eCollection 2022 Apr. PMID: 35372704 |
| 2021 | Osong B, Sanli I, Willems PC, Wee L, Dekker A, Lee SH, van Soest J. Overall survival nomogram for patients with spinal bone metastases (SBM). Clin Transl Radiat Oncol. 2021 Mar 11;28:48-53. doi: 10.1016/j.ctro.2021.02.010. eCollection 2021 May. |
| 2021 | Cho WK, Park W, Kim YS, Kang HC, Kim JH, Kim KS, Choi KH, Chang SK, Ahn KJ, Lee SH, Kim S, Kim J, Eom KY, Lee J, Lee JH, Choi JH. Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03). Eur J Obstet Gynecol Reprod Biol . 2021 Mar;258:396-400. doi: 10.1016/j.ejogrb.2021.01.034. Epub 2021 Jan 22. |
| 2020 | Kim YJ, Kim YS, Shin JW, Osong B, Lee SH (correspondence). Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation. Int J Gynecol Cancer . 2020 Nov;30(11):1689-1696. doi: 10.1136/ijgc-2019-001050. |
| 2019 | Lee JH, Lee SH (correspondence). Selecting the Appropriate Radiation Therapy Technique for Malignant Spinal Cord Compression Syndrome. Front Oncol. 2019; 9: 65. |
| 2018 | Kim H, Kim YS, Joo JH, Eom KY, Park W, Kim JH, Lee JH, Kim YS, Lee SH, Ahn K, Kim YB, Lee MY, Chang SK. Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).Int J Gynecol Cancer. 2018 Feb;28(2):371-378. |
| 2017 | Kwon J, Eom KY, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Res Treat.2017 Oct 24.doi: 10.4143/crt.2017.346 |
| 2017 | Lee SW, Lee SH, Kim J, Kim YS, Yoon MS, Jeong S, Kim JH, Lee J, Eom KY, Jeong BK, Sung SY, Lee SJ, Lee JH.Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01. GynecolOncol. 2017 Nov;147(2):334-339. |
| 2017 | Jung J, Kim YS, Joo JH, Park W, Lee JH, Kim JH, Yoon WS, Lee SH, Eom KY, Kim YB. Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10). Int J Gynecol Cancer. 2017 Sep;27(7):1387-1392. |
| 2017 | Ryu SH, Heo SH, Park EY, Choi KC, Ryu JW, Lee SH, Lee SW. Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes. Anticancer Res. 2017 Feb;37(2):607-614. |
| 2017 | Lee KC, Kim HJ, Sung K, Choi YE, Lee SH (correspondence), Lim S, Lee KB, Shin JW, Park CY, Kim YS, Sym SJ, Shim YS, Choi SJ. The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer. Int J Gynecol Cancer. 2017 Jan;27(1):123-130. |
| 2017 | Lim S, Lee SH, Lee KB, Park CY. The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation.ObstetGynecol Sci. 2016 May;59(3):184-91. Anticancer Res. 2017 Feb;37(2):607-614 |
| 2016 | Kang IG, Kim ST, Lee SH, Baek MK. Failed septal extension graft in a patient with a history of radiotherapy. MaxillofacPlastReconstr Surg. 2016 Oct 25;38(1):40. |
| 2016 | Lee SH, Kim HJ, Kim WC. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.Asia Pac J ClinOncol. 2016 Dec;12(4):388-395. |
| 2015 | Lee SH, Lee KC, Choi J, Ahn SH, Lee SH, Sung KH, Kil SH. Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy. Radiol Oncol. 2015 Mar 25;49(2):185-91. |
| <Presentation> |
| 2015 | The prognostic significance of tumor volume response and tumor marker changes during radiation therapy in cervical cancer patients (3rd international conference of federation of asian clinical oncology, Oral presentation) |
| 2014 | Assessment of tumor volume and serum tumor marker levels during chemoradiation therapy for cervix cancer (JSMO 2014, Poster) |
| 2005~현재 | 그 외 다수 국내외 학술대회 연구발표 |
| <최근 3년간 과제수행 현황> |
| 수술 전 항암방사선치료를 시행받은 직장암환자에서 부작용예측 및 병리학적 림프절 병기를 바탕으로 예후예측 모델링 구현 (The development of prediction modeling for treatment related toxicity and survival based on pathologic nodal staging of rectal cancer patients treated with neoadjuvant chemoradiation therapy) |
| 방사선치료를 시행 받은 자궁경부암 환자에서 임상병리학적 인자 기반 노모그램에 대한 후향적 검증 연구 |
| 유방전절제술 후 방사선치료에서 내유림프절 조사의 효과에 대한 3상 연구 |
| 조직학적으로 편평세포가 주된 세포가 아닌, 절제 불가능한 국소 진행성 제 3기 비소세포폐암 환자에서 페메트렉시드, 시스플라틴, 방사선요법 이후 페메트렉시드 강화요법 대비 에토포시드, 시스플라틴, 방사선요법 이후 선택에 따른 세포독성 화학요법 강화요법의 제 3상 임상시험 |
| Randomized, double-blind, placebo-controlled trial of Z-100 plus radiation therapy in patients with locally advanced cervical cancer-A phase Ⅲ trial, 국소적으로 진행된 자궁경부암 환자에서 방사선치료를 병행한 Z-100에 대한 무작위 배정 이중 맹검 위약대조 제 3상 임상시험. |
